-
Vaccibody Moving Forward with Cancer Neoantigen Vaccine Trial
americanpharmaceuticalreview
April 19, 2018
PharmaJet announced Vaccibody AS has received approval to start their cancer neoantigen trial using the PharmaJet Stratis needle-free injection system.
-
Sanofi Pasteur’s vaccine facility to be set up in Toronto
expressbpd
April 19, 2018
Governments of Canada and Ontario have announced an investment of up to $70 million towards Sanofi Pasteur’s $500-million project
-
R&D of Universal Flu Vaccine in the Darkness Before the Dawn
Muzi
April 17, 2018
We have to admit that the current flu vaccines are not satisfying! According to the world authoritative journal NEJM, less than half of people could not receive effective protection after flu vaccination.
-
Sanofi to invest in Canadian vaccine facility
biospectrumasia
April 16, 2018
The investment bolsters the company's Canadian operations and its commitment to advancing public health around the world.
-
Vaccine suppresses peanut allergies in mice
europeanpharmaceuticalreview
April 16, 2018
A vaccine may successfully turn off peanut allergy in mice, a new study shows.
-
Sanofi to invest €350m in new Canadian vaccine plant
pharmafile
April 13, 2018
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, according to the company, is one of its biggest-ever investments in a single building.
-
BiondVax Begins NIH-Sponsored Phase 2 Clinical Trial of Its Universal Flu Vaccine in the United States
biospace
April 12, 2018
The trial is sponsored by the US National Institute of Allergy and Infectious Disease.
-
H7N9 influenza vaccine clinical trials begin
europeanpharmaceuticalreview
March 20, 2018
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States…
-
TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical
biospace
March 16, 2018
TapImmune Inc. today announced the publication of clinical data
-
World’s first synthetic, non-biologic vaccine developed
pharmafile
March 15, 2018
One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the temperature regulated, with vaccines needing to stay at a cool temperature no matter the climate of the region in which they are transported.